Long noncoding RNA LINC01426 promotes the progression of lung adenocarcinoma via regulating miRNA-125a-5p/ casein kinase 2 alpha 1 axis

References

• Al-Lawati JA, Al-Bahrani BJ, Al-Lawati NA, et al. Epidemiology of lung cancer in oman: 20-Year trends and tumor characteristics. Oman Med J. 2019;34(5):397–403.
   PubMedGoogle Scholar
• Belanger AR, Hollyfield J, Yacovone G, et al. Incidence and clinical relevance of non-small cell lung cancer lymph node micro-metastasis detected by staging endobronchial ultrasound-guided transbronchial needle aspiration. J Thorac Dis. 2019;11(8):3650–3658.
   PubMed Web of Science ®Google Scholar
• Gesthalter Y, Smyth R. Treatment of small cell lung cancer. Am J Respir Crit Care Med. 2022;205(2):3–4.
   Google Scholar
• Lamort AS, Kaiser JC, Pepe MAA, et al. Prognostic phenotypes of early-stage lung adenocarcinoma. Eur Respir J. 2021;2101674. 10.1183/13993003.01674-2021.
   Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Nie M, Yao K, Zhu X, et al. Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma. Nat Commun. 2021;12(1):6479.
   PubMed Web of Science ®Google Scholar
• Abbastabar M, Sarfi M, Golestani A, et al. lncRNA involvement in hepatocellular carcinoma metastasis and prognosis. EXCLI J. 2018;17:900–913.
   PubMed Web of Science ®Google Scholar
• Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452–463.
   PubMed Web of Science ®Google Scholar
• Kallen AN, Zhou XB, Xu J, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013;52(1):101–112.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang Y, Li L, et al. LncRNA SNHG1 enhances cell proliferation, migration, and invasion in cervical cancer. Biochem Cell Biol. 2018;96(1):38–43.
   PubMedGoogle Scholar
• Yang J, Li C, Mudd A, et al. LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer. Biosci Biotechnol Biochem. 2017;81(12):2301–2306.
   PubMed Web of Science ®Google Scholar
• Zhuang C, Ma Q, Zhuang C, et al. LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC. FASEB J. 2019;33(10):11045–11059.
   PubMed Web of Science ®Google Scholar
• Zhou B, Li Z, Yang H, et al. Extracellular miRNAs: origin, function and biomarkers in hepatic diseases. J Biomed Nanotechnol. 2014;10(10):2865–2890.
   PubMed Web of Science ®Google Scholar
• Liu Y, Uzair Ur R, Guo Y, et al. miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4. Protein Cell. 2016;7(10):722–734.
   PubMed Web of Science ®Google Scholar
• Tang L, Zhou L, Wu S, et al. miR-125a-5p inhibits colorectal cancer cell epithelial-mesenchymal transition, invasion and migration by targeting TAZ. Onco Targets Ther. 2019;12:3481–3489.
   PubMedGoogle Scholar
• Zhang HD, Jiang LH, Hou JC, et al. Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer. Biomed Pharmacother. 2018;107:1342–1353.
   PubMed Web of Science ®Google Scholar
• Wang S, Ran L, Zhang W, et al. FOXS1 is regulated by GLI1 and miR-125a-5p and promotes cell proliferation and EMT in gastric cancer. Sci Rep. 2019;9(1):5281.
   PubMedGoogle Scholar
• Jiang Y, Zhang H, Li W, et al. LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1. J Cell Physiol. 2021;236(1):427–439.
   PubMed Web of Science ®Google Scholar
• Cao J, Tang Z, Su Z. Long non-coding RNA LINC01426 facilitates glioblastoma progression via sponging miR-345-3p and upregulation of VAMP8. Cancer Cell Int. 2020;20(1):327.
   PubMed Web of Science ®Google Scholar
• Wang SJ, Wang H, Zhao CD, et al. Long noncoding RNA LINC01426 promotes glioma progression through PI3K/AKT signaling pathway and serves as a prognostic biomarker. Eur Rev Med Pharmacol Sci. 2018;22(19):6358–6368.
   PubMed Web of Science ®Google Scholar
• Dai J, Wang B, Zhao Y, et al. Long noncoding RNA LINC01426 sequesters microRNA-519d-5p to promote non-small cell lung cancer progression by increasing ETS1 expression. Cancer Manag Res. 2020;12:12697–12708.
   PubMed Web of Science ®Google Scholar
• Li J, Wang J, Chen Y, et al. A prognostic 4-gene expression signature for squamous cell lung carcinoma. J Cell Physiol. 2017;232(12):3702–3713.
   PubMed Web of Science ®Google Scholar
• Li C, Tang Z, Zhang W, et al. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 2021;49(W1):W242–W6.
   PubMed Web of Science ®Google Scholar
• Liu D, Liu W, Chen X, et al. circKCNN2 suppresses the recurrence of hepatocellular carcinoma at least partially via regulating miR-520c-3p/methyl-DNA-binding domain protein 2 axis. Clin Transl Med. 2022;12(1):e662.
   PubMed Web of Science ®Google Scholar
• Li J, Hu ZQ, Yu S, et al. CircRPN2 inhibits aerobic glycolysis and metastasis in hepatocellular carcinoma. Cancer Res. 2022;1259.2021. 10.1158/0008-5472.CAN-21-1259.
   Google Scholar
• Yang C, Wu S, Mou Z, et al. Exosome derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironment through modulating reactive oxygen species equilibrium via GLS1 mediated glutamine metabolism alteration. Mol Ther. 2022; DOI:10.1016/j.ymthe.2022.01.022.
   Google Scholar
• Yang X, Li X, Zhong C, et al. Circular RNA circPHKA2 relieves OGD-Induced human brain microvascular endothelial cell injuries through competitively binding miR-574-5p to modulate SOD2. Oxid Med Cell Longev. 2021;2021:3823122.
   PubMed Web of Science ®Google Scholar
• Wang J, Wu H, Zhao Y, et al. Extracellular vesicles from HIF-1alpha-overexpressing adipose-derived stem cells restore diabetic wounds through accelerated fibroblast proliferation and migration. Int J Nanomedicine. 2021;16:7943–7957.
   PubMed Web of Science ®Google Scholar
• Jiang D, Wu X, Sun X, et al. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11. J Nanobiotechnology. 2022;20(1):29.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ng DY, Richards AM, et al. Loss of full-length pumilio 1 abrogates miRNA-221-induced gene p27 silencing-mediated cell proliferation in the heart. Mol Ther Nucleic Acids. 2022;27:456–470.
   PubMedGoogle Scholar
• Cao Q, Wang N, Ren L, et al. miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway. Cancer Cell Int. 2020;20(1):117.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang D, Lv J, et al. MiR-125a-5p suppresses bladder cancer progression through targeting FUT4. Biomed Pharmacother. 2018;108:1039–1047.
   PubMed Web of Science ®Google Scholar
• Xu X, Tao Y, Niu Y, et al. miR-125a-5p inhibits tumorigenesis in hepatocellular carcinoma. Aging (Albany NY). 2019;11(18):7639–7662.
   PubMedGoogle Scholar
• Minini M, Senni A, He X, et al. miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting. Cancer Lett. 2021;520:48–56.
   PubMed Web of Science ®Google Scholar
• Yan L, Yu MC, Gao GL, et al. MiR-125a-5p functions as a tumour suppressor in breast cancer by downregulating BAP1. J Cell Biochem. 2018;119(11):8773–8783.
   PubMed Web of Science ®Google Scholar
• Fan X, Liang Y, Liu Y, et al. The upregulation of TMPRSS4, partly ascribed to the downregulation of miR125a5p, promotes the growth of human lung adenocarcinoma via the NFkappaB signaling pathway. Int J Oncol. 2018;53(1):148–158.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Jiang L, Long X, et al. Clinical significance and integrative analysis of kinesin family member 18B in lung adenocarcinoma. Onco Targets Ther. 2019;12:9249–9264.
   PubMed Web of Science ®Google Scholar
• Gao S, Guo W, Liu T, et al. Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma. Cancer Sci. 2021;113(2):648–659.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Martinez A, Torres-Duran M, Barros-Dios JM, et al. Residential radon and small cell lung cancer. A systematic review. Cancer Lett. 2018;426:57–62.
   PubMed Web of Science ®Google Scholar
• Osuoha CA, Callahan KE, Ponce CP, et al. Disparities in lung cancer survival and receipt of surgical treatment. Lung Cancer. 2018;122:54–59.
   PubMed Web of Science ®Google Scholar
• Aisner DL, Marshall CB. Molecular pathology of non-small cell lung cancer: a practical guide. Am J Clin Pathol. 2012;138(3):332–346.
   PubMed Web of Science ®Google Scholar
• Gibbons DL, Byers LA, Kurie JM. Smoking, p53 mutation, and lung cancer. Mol Cancer Res. 2014;12(1):3–13.
   PubMed Web of Science ®Google Scholar
• Wu H, Zheng J, Deng J, et al. LincRNA-uc002yug.2 involves in alternative splicing of RUNX1 and serves as a predictor for esophageal cancer and prognosis. Oncogene. 2015;34(36):4723–4734.
   PubMed Web of Science ®Google Scholar
• Wu X, He X, Li S, et al. Long Non-Coding RNA ucoo2kmd.1 regulates CD44-Dependent cell growth by competing for miR-211-3p in colorectal cancer. PLoS One. 2016;11(3):e0151287.
   PubMed Web of Science ®Google Scholar
• Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 2003;113(6):673–676.
   PubMed Web of Science ®Google Scholar
• Niefind K, Guerra B, Ermakowa I, et al. Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme. EMBO J. 2001;20(19):5320–5331.
   PubMed Web of Science ®Google Scholar
• Wirkner U, Voss H, Ansorge W, et al. Genomic organization and promoter identification of the human protein kinase CK2 catalytic subunit alpha (CSNK2A1). Genomics. 1998;48(1):71–78.
   PubMed Web of Science ®Google Scholar
• Chen S, Wang Y, Xu M, et al. miR-1184 regulates the proliferation and apoptosis of colon cancer cells via targeting CSNK2A1. Mol Cell Probes. 2020;53:101625.
   PubMed Web of Science ®Google Scholar
• Jiang C, Ma Z, Zhang G, et al. CSNK2A1 promotes gastric cancer invasion through the PI3K-Akt-mTOR signaling pathway. Cancer Manag Res. 2019;11:10135–10143.
   PubMed Web of Science ®Google Scholar
• Shi Z, Wu D, Xu H, et al. CSNK2A1-mediated phosphorylation of HMGA2 modulates cisplatin resistance in cervical cancer. FEBS Open Bio. 2021;11(8):2245–2255.
   PubMed Web of Science ®Google Scholar
• Bae JS, Park SH, Jamiyandorj U, et al. CK2alpha/CSNK2A1 Phosphorylates SIRT6 and is involved in the progression of breast carcinoma and predicts shorter survival of diagnosed patients. Am J Pathol. 2016;186(12):3297–3315.
   PubMed Web of Science ®Google Scholar
• Wang H, Lv Q, Xu Y, et al. An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer. EBioMedicine. 2019;49:106–117.
   PubMed Web of Science ®Google Scholar
• Rabjerg M, Bjerregaard H, Halekoh U, et al. Molecular characterization of clear cell renal cell carcinoma identifies CSNK2A1, SPP1 and DEFB1 as promising novel prognostic markers. APMIS. 2016;124(5):372–383.
   PubMed Web of Science ®Google Scholar